|
R3HDM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76240000004935E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.35420000000075E-05 |
| Normal-vs-Stage2 |
3.688500E-02 |
| Normal-vs-Stage3 |
5.478400E-02 |
| Normal-vs-Stage4 |
5.728800E-01 |
| Stage1-vs-Stage2 |
8.314200E-01 |
| Stage1-vs-Stage3 |
7.907800E-01 |
| Stage1-vs-Stage4 |
4.315600E-01 |
| Stage2-vs-Stage3 |
7.415200E-01 |
| Stage2-vs-Stage4 |
4.994600E-01 |
| Stage3-vs-Stage4 |
6.443400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.53040000003568E-06 |
| Normal-vs-AfricanAmerican |
1.057780E-03 |
| Normal-vs-Asian |
8.882800E-01 |
| Caucasian-vs-AfricanAmerican |
9.125200E-01 |
| Caucasian-vs-Asian |
1.804960E-01 |
| AfricanAmerican-vs-Asian |
1.877790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27029999996697E-06 |
| Normal-vs-Female |
4.862000E-03 |
| Male-vs-Female |
3.683400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.901300E-03 |
| Normal-vs-Extreme_Weight |
9.162700E-03 |
| Normal-vs-Obese |
6.754300E-04 |
| Normal-vs-Extreme_Obese |
7.344400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.018000E-01 |
| Normal_Weight-vs-Obese |
3.794400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.056600E-01 |
| Extreme_Weight-vs-Obese |
1.755980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.651200E-01 |
| Obese-vs-Extreme_Obese |
8.701200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.606300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.49039999997047E-06 |
| Normal-vs-Age(61-80Yrs) |
8.596000E-04 |
| Normal-vs-Age(81-100Yrs) |
3.687400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.085200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.238600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.469600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.404640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.973200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.383400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.66930002943167E-09 |
| Normal-VS-Type2 PRCC |
1.757040E-01 |
| Normal-VS-KIRP CIMP |
2.359800E-03 |
| Normal-VS-Unclassified PRCC |
1.663680E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.841030E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.033410E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.944800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.058000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.703000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.51749999999629E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.862400E-02 |
| Normal-vs-N1 |
6.263500E-02 |
| Normal-vs-N2 |
1.852790E-01 |
| N0-vs-N1 |
4.449000E-01 |
| N0-vs-N2 |
3.430400E-01 |
| N1-vs-N2 |
7.716800E-01 |
|
|
